PIK3CA and cancer: Similarly, cancer pathway signatures such as the PI3K-pathway and Wnt-pathway were also enriched in the C1 subtype, leading to tumor development, which is consistent with the Type I UCEC report in other studies (Hussein and Soslow, 2018).